FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2034104731> ?p ?o ?g. }

• W2034104731 endingPage "1298" @default.
• W2034104731 startingPage "1292" @default.
• W2034104731 abstract "BackgroundMicrocystin-LR, a cyclic heptapeptide, possesses the ability to inhibit the serine/threonine protein phosphatases PP1 and PP2A and, consequently, exhibits acute hepatocytotoxicity. Moreover, microcystin-LR induces cellular proliferation, resulting in tumor-promoting activity in hepatocytes. However, mechanisms that regulate the balance between cell death and proliferation after microcystin-LR treatment remain unclear.ObjectiveWe examined the contribution of the transcription factor p53, as well as that of the hepatic uptake transporter for microcystin-LR, organic anion transporting polypeptide 1B3 (OATP1B3), to the cellular response to microcystin-LR exposure.MethodsWe analyzed intracellular signaling responses to microcystin-LR by immunoblotting and real-time reverse-transcriptase polymerase chain reaction techniques using HEK293 human embryonic kidney cells stably transfected with SLCO1B3 (HEK293-OATP1B3). In addition, we analyzed the effect of attenuation of p53 function, via the p53 inhibitor pifithrin-α, and knockdown of p53 mRNA on the cytotoxicity of microcystin-LR using a 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) assay.ResultsMicrocystin-LR induced the phosphorylation and accumulation of p53 in HEK293-OATP1B3 cells, which resulted in up-regulation of the expression of p53 transcript targets, including p21 and seven in absentia homolog 1 (siah-1). In addition, microcystin-LR activated Akt signaling through the phosphorylation of Akt and glycogen synthase kinase 3β. Although Akt signaling was activated, the accumulation of p53 led cells to apoptosis after treatment with 50 nM microcystin-LR for 24 hr. Both pharmacological inhibition of transcription factor activity of p53 by pifithrin-α and knockdown of p53 with small hairpin RNA attenuated the susceptibility of HEK293-OATP1B3 cells to microcystin-LR.ConclusionsThis study demonstrates the importance of p53 in the regulation of cell fate after exposure to microcystin-LR. Our results suggest that, under conditions of p53 inactivation (including p53 mutation), chronic exposure to low doses of microcystin-LR may lead to cell proliferation through activation of Akt signaling. Results of this study may contribute to the development of chemoprevention and chemotherapeutic approaches to microcystin-LR poisoning." @default.
• W2034104731 created "2016-06-24" @default.
• W2034104731 creator A5017035937 @default.
• W2034104731 creator A5022255783 @default.
• W2034104731 creator A5025326614 @default.
• W2034104731 creator A5032796164 @default.
• W2034104731 creator A5043038976 @default.
• W2034104731 creator A5059585512 @default.
• W2034104731 creator A5061203388 @default.
• W2034104731 creator A5067387824 @default.
• W2034104731 creator A5078379701 @default.
• W2034104731 creator A5086058908 @default.
• W2034104731 creator A5091243258 @default.
• W2034104731 date "2010-09-01" @default.
• W2034104731 modified "2023-10-16" @default.
• W2034104731 title "p53 Plays an Important Role in Cell Fate Determination after Exposure to Microcystin-LR" @default.
• W2034104731 cites W1500516885 @default.
• W2034104731 cites W1788032165 @default.
• W2034104731 cites W1795230821 @default.
• W2034104731 cites W1867818836 @default.
• W2034104731 cites W1965857762 @default.
• W2034104731 cites W1966133006 @default.
• W2034104731 cites W1982157932 @default.
• W2034104731 cites W1983225676 @default.
• W2034104731 cites W1984313735 @default.
• W2034104731 cites W1993720756 @default.
• W2034104731 cites W1996218569 @default.
• W2034104731 cites W1997927910 @default.
• W2034104731 cites W2003060606 @default.
• W2034104731 cites W2008257691 @default.
• W2034104731 cites W2012116432 @default.
• W2034104731 cites W2014630371 @default.
• W2034104731 cites W2015929270 @default.
• W2034104731 cites W2022309233 @default.
• W2034104731 cites W2023917814 @default.
• W2034104731 cites W2024413216 @default.
• W2034104731 cites W2024473765 @default.
• W2034104731 cites W2028592091 @default.
• W2034104731 cites W2033592111 @default.
• W2034104731 cites W2036935886 @default.
• W2034104731 cites W2039146724 @default.
• W2034104731 cites W2040306435 @default.
• W2034104731 cites W2051486745 @default.
• W2034104731 cites W2054334092 @default.
• W2034104731 cites W2059999514 @default.
• W2034104731 cites W2062203984 @default.
• W2034104731 cites W2065652048 @default.
• W2034104731 cites W2068336834 @default.
• W2034104731 cites W2069250897 @default.
• W2034104731 cites W2069545469 @default.
• W2034104731 cites W2072893511 @default.
• W2034104731 cites W2075188892 @default.
• W2034104731 cites W2079420389 @default.
• W2034104731 cites W2093423091 @default.
• W2034104731 cites W2096186886 @default.
• W2034104731 cites W2097092816 @default.
• W2034104731 cites W2097202616 @default.
• W2034104731 cites W2107277218 @default.
• W2034104731 cites W2108958930 @default.
• W2034104731 cites W2109995697 @default.
• W2034104731 cites W2113586978 @default.
• W2034104731 cites W2123674733 @default.
• W2034104731 cites W2125904354 @default.
• W2034104731 cites W2129912039 @default.
• W2034104731 cites W2139415460 @default.
• W2034104731 cites W2144396114 @default.
• W2034104731 cites W2145284999 @default.
• W2034104731 cites W2148423349 @default.
• W2034104731 cites W2152858404 @default.
• W2034104731 cites W2154111513 @default.
• W2034104731 cites W2156780879 @default.
• W2034104731 cites W2160226912 @default.
• W2034104731 cites W2160269020 @default.
• W2034104731 cites W2161322323 @default.
• W2034104731 cites W2165322824 @default.
• W2034104731 cites W2168875502 @default.
• W2034104731 cites W2169474553 @default.
• W2034104731 cites W2172051929 @default.
• W2034104731 cites W4256264762 @default.
• W2034104731 doi "https://doi.org/10.1289/ehp.1001899" @default.
• W2034104731 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/2944092" @default.
• W2034104731 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/20421190" @default.
• W2034104731 hasPublicationYear "2010" @default.
• W2034104731 type Work @default.
• W2034104731 sameAs 2034104731 @default.
• W2034104731 citedByCount "46" @default.
• W2034104731 countsByYear W20341047312012 @default.
• W2034104731 countsByYear W20341047312013 @default.
• W2034104731 countsByYear W20341047312014 @default.
• W2034104731 countsByYear W20341047312015 @default.
• W2034104731 countsByYear W20341047312016 @default.
• W2034104731 countsByYear W20341047312017 @default.
• W2034104731 countsByYear W20341047312019 @default.
• W2034104731 countsByYear W20341047312020 @default.
• W2034104731 countsByYear W20341047312023 @default.
• W2034104731 crossrefType "journal-article" @default.
• W2034104731 hasAuthorship W2034104731A5017035937 @default.
• W2034104731 hasAuthorship W2034104731A5022255783 @default.

• next